BIOMAT Database Logo BIOMAT Database Logo

Genes involved in bacitracin resistance in Streptococcus mutans. 2002

Hiromasa Tsuda, and Yoshihisa Yamashita, and Yukie Shibata, and Yoshio Nakano, and Toshihiko Koga
Department of Preventive Dentistry, Kyushu University Faculty of Dental Science, Fukuoka 812-8582, Japan.

Streptococcus mutans is resistant to bacitracin, which is a peptide antibiotic produced by certain species of Bacillus. The purpose of this study was to clarify the bacitracin resistance mechanism of S. mutans. We cloned and sequenced two S. mutans loci that are involved in bacitracin resistance. The rgp locus, which is located downstream from rmlD, contains six rgp genes (rgpA to rgpF) that are involved in rhamnose-glucose polysaccharide (RGP) synthesis in S. mutans. The inactivation of RGP synthesis in S. mutans resulted in an approximately fivefold-higher sensitivity to bacitracin relative to that observed for the wild-type strain Xc. The second bacitracin resistance locus comprised four mbr genes (mbrA, mbrB, mbrC, and mbrD) and was located immediately downstream from gtfC, which encodes the water-insoluble glucan-synthesizing enzyme. Although the bacitracin sensitivities of mutants that had defects in flanking genes were similar to that of the parental strain Xc, mutants that were defective in mbrA, mbrB, mbrC, or mbrD were about 100 to 120 times more sensitive to bacitracin than strain Xc. In addition, a mutant that was defective in all of the mbrABCD genes and rgpA was more sensitive to bacitracin than either the RGP or Mbr mutants. We conclude that RGP synthesis is related to bacitracin resistance in S. mutans and that the mbr genes modulate resistance to bacitracin via an unknown mechanism that is independent of RGP synthesis.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001414 Bacitracin A complex of cyclic peptide antibiotics produced by the Tracy-I strain of Bacillus subtilis. The commercial preparation is a mixture of at least nine bacitracins with bacitracin A as the major constituent. It is used topically to treat open infections such as infected eczema and infected dermal ulcers. (From Goodman and Gilman, The Pharmacological Basis of Therapeutics, 8th ed, p1140) Ak-Tracin,Altracin,Baci-IM,Baci-Rx,Baciguent,Bacitin,Bacitracin Zinc,Bacitracin Zinc Complex,Bacitracine Martinet,Ocu-Tracin,Topitracin,Zeba-Rx,Zinc Bacitracin,Ak Tracin,Baci IM,Baci Rx,Bacitracin, Zinc,Martinet, Bacitracine,Ocu Tracin,OcuTracin,Zeba Rx,Zinc, Bacitracin
D013295 Streptococcus mutans A polysaccharide-producing species of STREPTOCOCCUS isolated from human dental plaque.
D015698 Genomic Library A form of GENE LIBRARY containing the complete DNA sequences present in the genome of a given organism. It contrasts with a cDNA library which contains only sequences utilized in protein coding (lacking introns). Genome Library,Genome Libraries,Genomic Libraries,Libraries, Genome,Libraries, Genomic,Library, Genome,Library, Genomic
D024881 Drug Resistance, Bacterial The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance, Bacterial,Antibacterial Drug Resistance

Related Publications

Hiromasa Tsuda, and Yoshihisa Yamashita, and Yukie Shibata, and Yoshio Nakano, and Toshihiko Koga
Characterization of MbrC involved in bacitracin resistance in Streptococcus mutans.
May 2011, FEMS microbiology letters,
Hiromasa Tsuda, and Yoshihisa Yamashita, and Yukie Shibata, and Yoshio Nakano, and Toshihiko Koga
Bacitracin upregulates mbrAB transcription via mbrCD to confer bacitracin resistance in Streptococcus mutans.
January 2011, Journal of pharmacological sciences,
Hiromasa Tsuda, and Yoshihisa Yamashita, and Yukie Shibata, and Yoshio Nakano, and Toshihiko Koga
Multiple Streptococcus mutans Genes Are Involved in Biofilm Formation.
December 2002, Applied and environmental microbiology,
Hiromasa Tsuda, and Yoshihisa Yamashita, and Yukie Shibata, and Yoshio Nakano, and Toshihiko Koga
Transformation of fluoride resistance genes in Streptococcus mutans.
July 1989, Infection and immunity,
Hiromasa Tsuda, and Yoshihisa Yamashita, and Yukie Shibata, and Yoshio Nakano, and Toshihiko Koga
Exploring antibiofilm potential of bacitracin against streptococcus mutans.
December 2020, Microbial pathogenesis,
Hiromasa Tsuda, and Yoshihisa Yamashita, and Yukie Shibata, and Yoshio Nakano, and Toshihiko Koga
Identification of Streptococcus mutans genes involved in fluoride resistance by screening of a transposon mutant library.
December 2020, Molecular oral microbiology,
Hiromasa Tsuda, and Yoshihisa Yamashita, and Yukie Shibata, and Yoshio Nakano, and Toshihiko Koga
Genes involved in the repression of mutacin I production in Streptococcus mutans.
February 2009, Microbiology (Reading, England),
Hiromasa Tsuda, and Yoshihisa Yamashita, and Yukie Shibata, and Yoshio Nakano, and Toshihiko Koga
Expression of Streptococcus mutans gtf genes in Streptococcus milleri.
July 1992, Infection and immunity,
Hiromasa Tsuda, and Yoshihisa Yamashita, and Yukie Shibata, and Yoshio Nakano, and Toshihiko Koga
Glucose-sucrose-potassium tellurite-bacitracin agar, an alternative to mitis salivarius-bacitracin agar for enumeration of Streptococcus mutans.
October 1984, Journal of clinical microbiology,
Hiromasa Tsuda, and Yoshihisa Yamashita, and Yukie Shibata, and Yoshio Nakano, and Toshihiko Koga
Potential Risk of Spreading Resistance Genes within Extracellular-DNA-Dependent Biofilms of Streptococcus mutans in Response to Cell Envelope Stress Induced by Sub-MICs of Bacitracin.
August 2020, Applied and environmental microbiology,
Copied contents to your clipboard!